Updated: January 27, 2026
Atogepant Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

Summarize with AI
- How Does Atogepant Interact with Other Drugs?
- Category 1: Strong CYP3A4 Inhibitors (Increase Atogepant Levels — Dose Reduction Needed)
- Category 2: Strong and Moderate CYP3A4 Inducers (Decrease Atogepant Levels — Dose Increase Needed)
- Category 3: OATP Inhibitors (Increase Atogepant Levels — Dose Reduction Needed)
- Practical Interaction Quick Reference
- What to Tell Your Doctor and Pharmacist
Atogepant (Qulipta) interacts with CYP3A4-affecting drugs, OATP inhibitors, and more. Here's what to know and what to tell your doctor before starting it.
Atogepant (Qulipta) is metabolized primarily by a liver enzyme called CYP3A4, which means it can interact with many common medications. Some of these interactions require dose adjustments; others may require you to avoid certain medications entirely while taking atogepant. Knowing your interactions before you start is critical for safety.
This guide covers the most clinically relevant drug interactions with atogepant, explains what they mean in practical terms, and tells you what to share with your doctor and pharmacist.
How Does Atogepant Interact with Other Drugs?
Atogepant is metabolized by CYP3A4, a key enzyme in the liver that processes many medications. Drugs that affect CYP3A4 can either increase or decrease atogepant's blood levels, potentially leading to inadequate effect or toxicity. Additionally, atogepant is a substrate of certain drug transporters (OATP1B1, OATP1B3) that can be affected by other medications.
Category 1: Strong CYP3A4 Inhibitors (Increase Atogepant Levels — Dose Reduction Needed)
These medications slow down CYP3A4, causing atogepant to build up to higher-than-intended blood levels. If you take a strong CYP3A4 inhibitor with atogepant, the dose must be reduced to 10 mg once daily for episodic migraine. For chronic migraine, avoid using atogepant with strong CYP3A4 inhibitors altogether.
Common strong CYP3A4 inhibitors:
- Antifungals: ketoconazole (Nizoral), itraconazole (Sporanox), voriconazole (Vfend), posaconazole (Noxafil)
- Antibiotics: clarithromycin (Biaxin), telithromycin
- HIV antivirals (protease inhibitors): ritonavir, atazanavir, indinavir, cobicistat
- Grapefruit juice: inhibits intestinal CYP3A4; avoid or limit while taking atogepant
Category 2: Strong and Moderate CYP3A4 Inducers (Decrease Atogepant Levels — Dose Increase Needed)
CYP3A4 inducers speed up the enzyme, breaking down atogepant faster than normal and reducing its effectiveness. When used with strong or moderate CYP3A4 inducers, the recommended atogepant dose is 30–60 mg once daily to maintain efficacy.
Common CYP3A4 inducers:
- Antibiotics: rifampin (Rifadin, Rimactane) — significant inducer
- Antiepileptics: carbamazepine (Carbatrol, Tegretol), phenytoin (Dilantin), phenobarbital
- HIV antivirals: efavirenz (Sustiva), etravirine (Intelence), nevirapine
- Herbal supplement: St. John's Wort — a commonly used OTC herbal supplement that is a potent CYP3A4 inducer. Avoid while taking atogepant.
Category 3: OATP Inhibitors (Increase Atogepant Levels — Dose Reduction Needed)
Atogepant is also a substrate of OATP1B1 and OATP1B3 transporters, which help move drugs into the liver for processing. Inhibiting these transporters increases atogepant blood levels. When combined with OATP inhibitors, reduce atogepant dose to 10 mg or 30 mg per day.
Common OATP inhibitors:
- Cyclosporine — immunosuppressant used after organ transplant
- Fostemsavir — HIV antiviral; avoid combination or use lowest atogepant dose
- Leniolisib — may significantly increase atogepant exposure
Practical Interaction Quick Reference
- Strong CYP3A4 inhibitor + atogepant: 10 mg/day (episodic only); avoid for chronic migraine
- Strong/moderate CYP3A4 inducer + atogepant: 30–60 mg/day
- OATP inhibitor + atogepant: 10–30 mg/day
- St. John's Wort + atogepant: Avoid; significant CYP3A4 induction reduces atogepant efficacy
- Grapefruit juice + atogepant: Avoid or limit; inhibits intestinal CYP3A4
What to Tell Your Doctor and Pharmacist
Before starting atogepant, provide a complete list of all medications, supplements, and herbal products you take. Be sure to mention:
- Any antifungals (even short courses taken for infections)
- HIV medications (especially protease inhibitors or NNRTIs)
- Antiepileptic drugs, especially carbamazepine or phenytoin
- St. John's Wort or any other herbal supplements
- Cyclosporine or other immunosuppressants (for transplant patients)
- Any kidney or liver conditions that might affect drug processing
For more on atogepant's side effects and safety profile, see our guide on atogepant side effects.
Frequently Asked Questions
The most clinically significant interactions are with CYP3A4 inhibitors (like ketoconazole, itraconazole, clarithromycin), CYP3A4 inducers (like rifampin, carbamazepine, phenytoin, St. John's Wort), and OATP inhibitors (like cyclosporine). These interactions require dose adjustments or avoidance. Always give your doctor and pharmacist a complete list of all your medications before starting atogepant.
No. St. John's Wort is a potent CYP3A4 inducer that significantly reduces atogepant blood levels, potentially making it ineffective for migraine prevention. Avoid St. John's Wort while taking atogepant. Inform your doctor and pharmacist if you have been taking it before starting atogepant.
You should avoid or limit grapefruit juice while taking atogepant. Grapefruit inhibits intestinal CYP3A4, which can increase atogepant blood levels. While this interaction is not as dramatic as with some other medications, it's safest to avoid regular consumption of grapefruit or grapefruit juice during treatment.
If you're taking a strong CYP3A4 inhibitor (like ketoconazole, itraconazole, or clarithromycin) with atogepant for episodic migraine, reduce the dose to 10 mg once daily. For chronic migraine, avoid the combination altogether. Always confirm the appropriate dose with your prescriber, as individual circumstances vary.
Yes. Carbamazepine (Tegretol) and phenytoin (Dilantin) are CYP3A4 inducers that can reduce atogepant blood levels significantly, decreasing its effectiveness. If you take one of these antiepileptic drugs, your doctor may need to prescribe a higher dose of atogepant (30–60 mg/day) to achieve adequate migraine prevention.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Atogepant also looked for:
More about Atogepant
30,130 have already found their meds with Medfinder.
Start your search today.





